-
Bupa fined A$35m in Australia for misleading customers in health insurance claims
Bupa admits to misleading thousands of health insurance customers and unconscionably denying legitimate claims over more than five years.
-
Clearing firm fined for surveillance lapses related to potentially manipulative trading
FINRA outlined failure to implement effective supervisory and surveillance practices for trading and business communications recordkeeping.
-
FINRA disciplinary action update 2025/24
Disciplinary decisions issued June 21 – 27, 2025.
-
Asia-Pacific in focus: June 2025 at a glance
The latest in our new series of roundups from the financial regulation industries across the Asia-Pacific region.
-
CVS Caremark’s $95m penalty for Medicare drug overbilling
Whistleblower alleged Caremark reported higher costs of drugs to the government than it paid pharmacies for dispensing Medicare Part D drugs.
-
Apple makes last-minute changes to App Store policies in EU to avoid fine
Announcement is latest episode in tense stand-off between European regulators and US tech giants.
-
FINRA updates rules and rethinks oversight with broader input
FINRA’s latest board meeting brought key rule changes, expanded advisory input, and fresh focus on financial and cybersecurity oversight.
-
Crypto wrap: EU stablecoin plans, Singapore crypto crackdown, plus more
A summary of the latest news and developments in the world of crypto.